Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases,
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …

Background Functional impairment of interferon, a natural antiviral component of the
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …

Importance Certain individuals, when infected by SARS-CoV-2, tend to develop the more
severe forms of Covid-19 illness for reasons that remain unclear. Objective To determine the …

Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …

Introduction More than 93,000 cases of coronavirus disease (COVID-19) have been reported
worldwide. We describe the epidemiology, clinical course, and virologic characteristics of …

Patients with inflammatory bowel disease (IBD), namely ulcerative colitis (UC) and Crohn's
disease (CD), have worse outcomes with Clostridium difficile infection (CDI), including …

Importance Although quality improvement (QI) interventions can reduce central–line-associated
bloodstream infections (CLABSI) and catheter-related bloodstream infections (CRBSI), …

Objective We sought to determine the extent of SARS-CoV-2 seroprevalence and the factors
associated with seroprevalence across a diverse cohort of healthcare workers. Design …

BACKGROUNDAntibiotic treatment for asymptomatic bacteriuria (ASB) is prevalent but often
contrary to published guidelines.OBJECTIVETo evaluate risk factors for treatment of ASB.…

Objectives This article is one of a series on acute, severe diseases of humans caused by
emerging viruses for which there are no or limited licensed medical countermeasures. We …